Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 153889
Author(s) Storici, P; Capitani, G; Müller, R; Schirmer, T; Jansonius, J N
Author(s) at UniBasel Schirmer, Tilman
Year 1999
Title Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine
Journal Journal of molecular biology
Volume 285
Number 1
Pages / Article-Number 297-309
Keywords 6-aminotransferase, crystal structure, substrate analogue, suicide inhibitor, 5-fluoromethylornithine
Abstract Ornithine aminotransferase (l-ornithine:2-oxoacid delta-aminotransferase; EC 2.6.1.13), a pyridoxal-5'-phosphate-dependent mitochondrial enzyme controls the l-ornithine level in tissues by catalyzing the transfer of the delta-amino group of l-ornithine to 2-oxoglutarate, producing l-glutamate- gamma-semialdehyde and l-glutamate. (2S, 5S)-5-Fluoromethylornithine is the only inhibitor exclusively specific for ornithine aminotransferase known to date. Both in vitro and in vivo, it blocks the enzyme by a suicide reaction leading to a covalent adduct with the cofactor. The crystal structure of the enzyme-inhibitor complex was solved at a resolution of 1.95 A. No significant conformational changes compared with the native enzyme structure were observed. The structure reveals the atomic details of the cofactor-inhibitor adduct and its interactions with the active site of the enzyme. The main residues responsible for specific binding of the inhibitor are Arg180, which forms a strong salt bridge with the alpha-carboxylate and Tyr55, which is involved in a short hydrogen bond with the alpha-amino group. The experimental observation that in the racemic mixture, (2S, 5S)-5-fluoromethylornithine is exclusively responsible for the enzyme inhibition can be explained on the basis of the active site topology. Model building studies strongly suggest that the natural substrate l-ornithine, in its external aldimine adduct with the enzyme, makes use of the same recognition site as the inhibitor. It is proposed that the neutralization of the active site Arg413 by a salt bridge with Glu235 also plays an important role in productive binding of both 5-fluoromethylornithine and l-ornithine. Arg180 and Arg413 are believed to be instrumental in recognition of l-glutamate, by binding its gamma and alpha-carboxylate groups, respectively. This requires a different side-chain conformation of Glu235. Lys292 is the only obvious candidate for catalyzing the rate-limiting proton transfer steps in the transamination reaction.
Publisher Elsevier
ISSN/ISBN 0022-2836
edoc-URL http://edoc.unibas.ch/dok/A5258268
Full Text on edoc No
Digital Object Identifier DOI 10.1006/jmbi.1998.2289
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/9878407
ISI-Number WOS:000077968200025
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.353 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024